BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 28375942)

  • 1. Butyrylcholinesterase as a Blood Biomarker in Neuroblastoma.
    Coulter DW; Boettner AD; Kortylewicz ZP; Enke SP; Luther JA; Verma V; Baranowska-Kortylewicz J
    J Pediatr Hematol Oncol; 2017 May; 39(4):272-281. PubMed ID: 28375942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo angiogenic activity of neuroblastoma correlates with MYCN oncogene overexpression.
    Ribatti D; Raffaghello L; Pastorino F; Nico B; Brignole C; Vacca A; Ponzoni M
    Int J Cancer; 2002 Dec; 102(4):351-4. PubMed ID: 12402304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Pilot Study on the Utility of Serum Metabolomics in Neuroblastoma Patients and Xenograft Models.
    Beaudry P; Campbell M; Dang NH; Wen J; Blote K; Weljie AM
    Pediatr Blood Cancer; 2016 Feb; 63(2):214-20. PubMed ID: 26481088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic alterations of plasma cell free DNA in response to chemotherapy in children with neuroblastoma.
    Su Y; Wang L; Wang X; Yue Z; Xing T; Zhao W; Zhao Q; Duan C; Huang C; Han Y; Qiu L; Cheng X; Liu Y; Ma X
    Cancer Med; 2019 Apr; 8(4):1558-1566. PubMed ID: 30793512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The angiogenic growth factors HGF and VEGF in serum and plasma from neuroblastoma patients.
    Sköldenberg EG; Larsson A; Jakobson A; Hedborg F; Kogner P; Christofferson RH; Azarbayjani F
    Anticancer Res; 2009 Aug; 29(8):3311-9. PubMed ID: 19661350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of a neuroblastoma mouse model by subcutaneous xenograft transplantation and its use to study metastatic neuroblastoma.
    Gao Q; Chen CF; Dong Q; Hou L; Chen X; Zhi YL; Li X; Lu HT; Zhang HY
    Genet Mol Res; 2015 Dec; 14(4):16297-307. PubMed ID: 26662423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum protein profiling to identify high-risk neuroblastoma: preclinical relevance of blood-based biomarkers.
    Sandoval JA; Turner KE; Hoelz DJ; Rescorla FJ; Hickey RJ; Malkas LH
    J Surg Res; 2007 Oct; 142(2):268-74. PubMed ID: 17727886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PlGF and VEGF-A Regulate Growth of High-Risk MYCN-Single Copy Neuroblastoma Xenografts via Different Mechanisms.
    Zins K; Kovatchki D; Lucas T; Abraham D
    Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating microRNA: a new candidate for diagnostic biomarker in neuroblastoma.
    Mohammadi M; Goodarzi M; Jaafari MR; Mirzaei HR; Mirzaei H
    Cancer Gene Ther; 2016 Nov; 23(11):371-372. PubMed ID: 27740613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of plasma complement C3 as a potential biomarker for neuroblastoma using a quantitative proteomic approach.
    Kim PY; Tan O; Diakiw SM; Carter D; Sekerye EO; Wasinger VC; Liu T; Kavallaris M; Norris MD; Haber M; Chesler L; Dolnikov A; Trahair TN; Cheung NK; Marshall GM; Cheung BB
    J Proteomics; 2014 Jan; 96():1-12. PubMed ID: 24200836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum-circulating miRNAs predict neuroblastoma progression in mouse model of high-risk metastatic disease.
    Ramraj SK; Aravindan S; Somasundaram DB; Herman TS; Natarajan M; Aravindan N
    Oncotarget; 2016 Apr; 7(14):18605-19. PubMed ID: 26921195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum-Based Quantification of MYCN Gene Amplification in Young Patients with Neuroblastoma: Potential Utility as a Surrogate Biomarker for Neuroblastoma.
    Yagyu S; Iehara T; Tanaka S; Gotoh T; Misawa-Furihata A; Sugimoto T; London WB; Hogarty MD; Teramukai S; Nakagawara A; Hiyama E; Maris JM; Hosoi H
    PLoS One; 2016; 11(8):e0161039. PubMed ID: 27513929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophagy is associated with chemoresistance in neuroblastoma.
    Belounis A; Nyalendo C; Le Gall R; Imbriglio TV; Mahma M; Teira P; Beaunoyer M; Cournoyer S; Haddad E; Vassal G; Sartelet H
    BMC Cancer; 2016 Nov; 16(1):891. PubMed ID: 27846885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Five Neuroblastoma Genes in Bone Marrow or Blood of Patients with Relapsed/Refractory Neuroblastoma Provides a New Biomarker for Disease and Prognosis.
    Marachelian A; Villablanca JG; Liu CW; Liu B; Goodarzian F; Lai HA; Shimada H; Tran HC; Parra JA; Gallego R; Bedrossian N; Young S; Czarnecki S; Kennedy R; Weiss BD; Goldsmith K; Granger M; Matthay KK; Groshen S; Asgharzadeh S; Sposto R; Seeger RC
    Clin Cancer Res; 2017 Sep; 23(18):5374-5383. PubMed ID: 28559462
    [No Abstract]   [Full Text] [Related]  

  • 15. Soluble HLA-G and HLA-E Levels in Bone Marrow Plasma Samples Are Related to Disease Stage in Neuroblastoma Patients.
    Morandi F; Pozzi S; Carlini B; Amoroso L; Pistoia V; Corrias MV
    J Immunol Res; 2016; 2016():7465741. PubMed ID: 27610393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptide Y as a Biomarker and Therapeutic Target for Neuroblastoma.
    Galli S; Naranjo A; Van Ryn C; Tilan JU; Trinh E; Yang C; Tsuei J; Hong SH; Wang H; Izycka-Swieszewska E; Lee YC; Rodriguez OC; Albanese C; Kitlinska J
    Am J Pathol; 2016 Nov; 186(11):3040-3053. PubMed ID: 27743558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroblastoma in adolescents: the Italian experience.
    Conte M; Parodi S; De Bernardi B; Milanaccio C; Mazzocco K; Angelini P; Viscardi E; Di Cataldo A; Luksch R; Haupt R
    Cancer; 2006 Mar; 106(6):1409-17. PubMed ID: 16475209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldehyde dehydrogenase activity plays a Key role in the aggressive phenotype of neuroblastoma.
    Flahaut M; Jauquier N; Chevalier N; Nardou K; Balmas Bourloud K; Joseph JM; Barras D; Widmann C; Gross N; Renella R; Mühlethaler-Mottet A
    BMC Cancer; 2016 Oct; 16(1):781. PubMed ID: 27724856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BLM germline and somatic PKMYT1 and AHCY mutations: Genetic variations beyond MYCN and prognosis in neuroblastoma.
    Novak EM; Halley NS; Gimenez TM; Rangel-Santos A; Azambuja AM; Brumatti M; Pereira PL; Vince CS; Giorgi RR; Bendit I; Cristofani LM; Odone-Filho V
    Med Hypotheses; 2016 Dec; 97():22-25. PubMed ID: 27876123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [N-myc gene copies in children with neuroblastoma and its clinical significance].
    Ma XL; Gong LP; Zhou CJ; Zhang DW; Jin M; Wang HM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1447-51. PubMed ID: 23257451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.